Anyway, we observed a significant down-regulation of CBX2 in optimal responder patients: this gene has been reported to play an oncogenic role, with its up-regulation being able to predict progression and shorter OS in multiple cancer types (25). This evidence concerns the gene CBX2 and cancer.